Acute blood purification
Offering renal care and beyond
Acute blood purification is based on extracorporeal treatment of blood and includes procedures to clean blood from toxins and pathogenic agents. Our main focus is on the treatment of acute kidney injury (AKI). It is founded on continuous kidney replacement therapy (CKRT), an extracorporeal procedure to slowly and still effectively clean blood from uremic toxins and other nitrogenous waste by making use of its ideally continuous application. This also includes managing fluid balance by low but sustained net ultrafiltration rates. CKRT is also known as CRRT, or continuous renal replacement therapy.
Reflecting our comprehensivemulti-organ supportapproach, we further provide products and services that allow therapy diversity beyondCKRT, including the integration of certain adsorbers when AKI is associated withsepsis, extracorporeal carbon dioxide removal (ECCO2R) in certain patients with acute respiratory dysfunction syndrome as well astherapeutic plasma exchange.
In CKRT, Ģý is committed to侱ĢýCregional citrate anticoagulation. We were the first to offer a comprehensive 侱ĢýC therapy concept and product range, designed to improve anticoagulation in CKRT and reduce risks of bleeding complications.